Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0314581 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Takuto Nosaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
To cure hepatitis B virus (HBV) infection, it is essential to elucidate the function of hepatocyte host factors in regulating the viral life cycle. Signaling and transcription activator of transcription (STAT)1 play important roles in immune responses, but STAT1-independent pathways have also been shown to have important biological reactivity. Using an in vitro HBV infection assay system, the current study aimed to investigate the STAT1-independent host factors that contribute to the control of viral infection by comprehensive functional screening. The in vitro HBV infection system was established using primary human hepatocytes (PXB cells) infected with HBV derived from a plasmid containing the 1.3-mer HBV genome. Comprehensive functional studies were performed using small interfering RNA (siRNA) and vector transfection and analyzed using microarrays. Knockdown of STAT1 increased viral products in HBV-transfected HepG2 cells, but decreased in HBV-infected PXB cells. RNA microarray was performed using HBV-infected PXB cells with STAT1 knockdown. Fumarylacetoacetate hydrolase (FAH) was extracted by siRNA of genes in PXB cells altered by STAT1 knockdown. Transfection of FAH inhibited HBV replication. Dimethyl fumarate (DMF), the methyl ester of FAH metabolite, showed antiviral effects by inducing autophagy and anti-HBV-related genes. Independently of STAT1, FAH was identified as a host factor that contributes to the control of viral infection, and its metabolite, DMF, exhibited antiviral activity. These results suggest that the novel host factor FAH and its metabolites may be an innovative therapeutic strategy to control the HBV life cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
- Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Tochigi, Japan.
ORCID-Profile: Yasunari Nakamoto
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science KAKENHI
Zitieren
APA
Nosaka, T., Naito, T., Akazawa, Y., Takahashi, K., Matsuda, H., Ohtani, M., Nishizawa, T., Okamoto, H., & Nakamoto, Y. (2025). Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems. PLOS ONE. https://doi.org/10.1371/journal.pone.0314581
Vancouver
Nosaka T, Naito T, Akazawa Y, Takahashi K, Matsuda H, Ohtani M, et al. Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems. PLOS ONE. 2025. doi:10.1371/journal.pone.0314581
BibTeX
@article{Nosaka2025,
author = {Nosaka, Takuto and Naito, Tatsushi and Akazawa, Yu and Takahashi, Kazuto and Matsuda, Hidetaka and Ohtani, Masahiro and Nishizawa, Tsutomu and Okamoto, Hiroaki and Nakamoto, Yasunari},
title = {Identification of novel antiviral host factors by functional gene expression analysis using in vitro HBV infection assay systems},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0314581}
}
EUVIMED